APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hyperthermia Treatment for Cancer

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hyperthermia Treatment for Cancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025185 pages

Choose your research edition.

Industry ResearchHyperthermia Treatment for Cancer Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Hyperthermia Treatment for Cancer Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Hyperthermia Treatment for Cancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hyperthermia Treatment for Cancer Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hyperthermia Treatment for Cancer Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Hyperthermia Treatment for Cancer market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hyperthermia Treatment for Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hyperthermia Treatment for Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hyperthermia Treatment for Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hyperthermia Treatment for Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hyperthermia Treatment for Cancer include Sjn AG Yamamoto Vinita, Pyrexar Medical, Perseon Medical, Omron Corporation, Huahang, Celsius42 GmbH and Andromedic Sri, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hyperthermia Treatment for Cancer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hyperthermia Treatment for Cancer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hyperthermia Treatment for Cancer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hyperthermia Treatment for Cancer market size, projected growth trends, production technologies, key applications, and end-use industries.

Hyperthermia Treatment for Cancer Segment by Company

Sjn AG Yamamoto Vinita

Pyrexar Medical

Perseon Medical

Omron Corporation

Huahang

Celsius42 GmbH

Andromedic Sri

Hyperthermia Treatment for Cancer Segment by Type

Ultrasound Hyperthermia Device

Short-Wave Therapy Device

Infrared Therapy Device

Microwave Hyperthermia Device

Hyperthermia Treatment for Cancer Segment by Application

Clinics

Hospitals

Research Institutes

Hyperthermia Treatment for Cancer Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperthermia Treatment for Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyperthermia Treatment for Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperthermia Treatment for Cancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hyperthermia Treatment for Cancer market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hyperthermia Treatment for Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hyperthermia Treatment for Cancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hyperthermia Treatment for Cancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hyperthermia Treatment for Cancer Industry Trends Table 2. Hyperthermia Treatment for Cancer Industry Drivers Table 3. Hyperthermia Treatment for Cancer Industry Opportunities and Challenges Table 4. Hyperthermia Treatment for Cancer Industry Restraints Table 5. Global Hyperthermia Treatment for Cancer Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hyperthermia Treatment for Cancer Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hyperthermia Treatment for Cancer Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hyperthermia Treatment for Cancer Sales Market Share by Manufacturers Table 9. Global Hyperthermia Treatment for Cancer Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hyperthermia Treatment for Cancer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hyperthermia Treatment for Cancer Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hyperthermia Treatment for Cancer Manufacturers, Product Type & Application Table 13. Global Hyperthermia Treatment for Cancer Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hyperthermia Treatment for Cancer by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ultrasound Hyperthermia Device Table 17. Major Manufacturers of Short-Wave Therapy Device Table 18. Major Manufacturers of Infrared Therapy Device Table 19. Major Manufacturers of Microwave Hyperthermia Device Table 20. Global Hyperthermia Treatment for Cancer Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Hyperthermia Treatment for Cancer Sales by Type (2021-2026) & (K Units) Table 22. Global Hyperthermia Treatment for Cancer Sales by Type (2027-2032) & (K Units) Table 23. Global Hyperthermia Treatment for Cancer Sales Market Share by Type (2021-2026) Table 24. Global Hyperthermia Treatment for Cancer Sales Market Share by Type (2027-2032) Table 25. Global Hyperthermia Treatment for Cancer Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Hyperthermia Treatment for Cancer Revenue by Type (2021-2026) & (K Units) Table 27. Global Hyperthermia Treatment for Cancer Revenue by Type (2027-2032) & (K Units) Table 28. Global Hyperthermia Treatment for Cancer Revenue Market Share by Type (2021-2026) Table 29. Global Hyperthermia Treatment for Cancer Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Research Institutes Table 33. Global Hyperthermia Treatment for Cancer Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Hyperthermia Treatment for Cancer Sales by Application (2021-2026) & (K Units) Table 35. Global Hyperthermia Treatment for Cancer Sales by Application (2027-2032) & (K Units) Table 36. Global Hyperthermia Treatment for Cancer Sales Market Share by Application (2021-2026) Table 37. Global Hyperthermia Treatment for Cancer Sales Market Share by Application (2027-2032) Table 38. Global Hyperthermia Treatment for Cancer Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Hyperthermia Treatment for Cancer Revenue by Application (2021-2026) & (K Units) Table 40. Global Hyperthermia Treatment for Cancer Revenue by Application (2027-2032) & (K Units) Table 41. Global Hyperthermia Treatment for Cancer Revenue Market Share by Application (2021-2026) Table 42. Global Hyperthermia Treatment for Cancer Revenue Market Share by Application (2027-2032) Table 43. Global Hyperthermia Treatment for Cancer Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Hyperthermia Treatment for Cancer Sales by Region (2021-2026) & (K Units) Table 45. Global Hyperthermia Treatment for Cancer Sales Market Share by Region (2021-2026) Table 46. Global Hyperthermia Treatment for Cancer Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Hyperthermia Treatment for Cancer Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Hyperthermia Treatment for Cancer Sales by Country (2021-2026) & (K Units) Table 50. North America Hyperthermia Treatment for Cancer Sales by Country (2027-2032) & (K Units) Table 51. Europe Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Hyperthermia Treatment for Cancer Sales by Country (2021-2026) & (K Units) Table 53. Europe Hyperthermia Treatment for Cancer Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Hyperthermia Treatment for Cancer Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Hyperthermia Treatment for Cancer Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales by Country (2027-2032) & (K Units) Table 60. Global Hyperthermia Treatment for Cancer Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Hyperthermia Treatment for Cancer Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Hyperthermia Treatment for Cancer Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Hyperthermia Treatment for Cancer Revenue Market Share by Region (2021-2026) Table 64. Global Hyperthermia Treatment for Cancer Revenue Market Share by Region (2027-2032) Table 65. Sjn AG Yamamoto Vinita Company Information Table 66. Sjn AG Yamamoto Vinita Business Overview Table 67. Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Product Portfolio Table 69. Sjn AG Yamamoto Vinita Recent Development Table 70. Pyrexar Medical Company Information Table 71. Pyrexar Medical Business Overview Table 72. Pyrexar Medical Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Pyrexar Medical Hyperthermia Treatment for Cancer Product Portfolio Table 74. Pyrexar Medical Recent Development Table 75. Perseon Medical Company Information Table 76. Perseon Medical Business Overview Table 77. Perseon Medical Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Perseon Medical Hyperthermia Treatment for Cancer Product Portfolio Table 79. Perseon Medical Recent Development Table 80. Omron Corporation Company Information Table 81. Omron Corporation Business Overview Table 82. Omron Corporation Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Omron Corporation Hyperthermia Treatment for Cancer Product Portfolio Table 84. Omron Corporation Recent Development Table 85. Huahang Company Information Table 86. Huahang Business Overview Table 87. Huahang Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Huahang Hyperthermia Treatment for Cancer Product Portfolio Table 89. Huahang Recent Development Table 90. Celsius42 GmbH Company Information Table 91. Celsius42 GmbH Business Overview Table 92. Celsius42 GmbH Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Celsius42 GmbH Hyperthermia Treatment for Cancer Product Portfolio Table 94. Celsius42 GmbH Recent Development Table 95. Andromedic Sri Company Information Table 96. Andromedic Sri Business Overview Table 97. Andromedic Sri Hyperthermia Treatment for Cancer Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Andromedic Sri Hyperthermia Treatment for Cancer Product Portfolio Table 99. Andromedic Sri Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Hyperthermia Treatment for Cancer Distributors List Table 103. Hyperthermia Treatment for Cancer Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Hyperthermia Treatment for Cancer Product Image Figure 2. Global Hyperthermia Treatment for Cancer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hyperthermia Treatment for Cancer Market Size (2021-2032) & (US$ Million) Figure 4. Global Hyperthermia Treatment for Cancer Sales (2021-2032) & (K Units) Figure 5. Global Hyperthermia Treatment for Cancer Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hyperthermia Treatment for Cancer Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ultrasound Hyperthermia Device Image Figure 9. Short-Wave Therapy Device Image Figure 10. Infrared Therapy Device Image Figure 11. Microwave Hyperthermia Device Image Figure 12. Global Hyperthermia Treatment for Cancer Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Hyperthermia Treatment for Cancer Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Hyperthermia Treatment for Cancer Sales Market Share by Type (2021-2032) Figure 15. Global Hyperthermia Treatment for Cancer Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Hyperthermia Treatment for Cancer Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Hyperthermia Treatment for Cancer Revenue Market Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitals Image Figure 20. Research Institutes Image Figure 21. Global Hyperthermia Treatment for Cancer Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Hyperthermia Treatment for Cancer Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hyperthermia Treatment for Cancer Sales Market Share by Application (2021-2032) Figure 24. Global Hyperthermia Treatment for Cancer Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Hyperthermia Treatment for Cancer Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hyperthermia Treatment for Cancer Revenue Market Share by Application (2021-2032) Figure 27. North America Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Hyperthermia Treatment for Cancer Sales Market Share by Country (2021-2032) Figure 29. U.S. Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Hyperthermia Treatment for Cancer Sales Market Share by Country (2021-2032) Figure 34. Germany Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Country (2021-2032) Figure 41. China Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Country (2021-2032) Figure 49. Brazil Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Hyperthermia Treatment for Cancer Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Hyperthermia Treatment for Cancer Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Hyperthermia Treatment for Cancer Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Hyperthermia Treatment for Cancer Revenue (2021-2032) & (US$ Million) Figure 60. North America Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Hyperthermia Treatment for Cancer Revenue (2021-2032) & (US$ Million) Figure 62. Europe Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Hyperthermia Treatment for Cancer Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Hyperthermia Treatment for Cancer Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hyperthermia Treatment for Cancer Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hyperthermia Treatment for Cancer Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ultrasound Hyperthermia Device
  • Short-Wave Therapy Device
  • Infrared Therapy Device
  • Microwave Hyperthermia Device
Applications
  • Clinics
  • Hospitals
  • Research Institutes
Companies covered
  • Sjn AG Yamamoto Vinita
  • Pyrexar Medical
  • Perseon Medical
  • Omron Corporation
  • Huahang
  • Celsius42 GmbH
  • Andromedic Sri

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hyperthermia Treatment for Cancer Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hyperthermia Treatment for Cancer Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hyperthermia Treatment for Cancer Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hyperthermia Treatment for Cancer Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hyperthermia Treatment for Cancer Market Dynamics
  1. 2.1 Hyperthermia Treatment for Cancer Industry Trends
  2. 2.2 Hyperthermia Treatment for Cancer Industry Drivers
  3. 2.3 Hyperthermia Treatment for Cancer Industry Opportunities and Challenges
  4. 2.4 Hyperthermia Treatment for Cancer Industry Restraints
3 Hyperthermia Treatment for Cancer Market by Manufacturers
  1. 3.1 Global Hyperthermia Treatment for Cancer Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hyperthermia Treatment for Cancer Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hyperthermia Treatment for Cancer Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hyperthermia Treatment for Cancer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hyperthermia Treatment for Cancer Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hyperthermia Treatment for Cancer Manufacturers, Product Type & Application
  7. 3.7 Global Hyperthermia Treatment for Cancer Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hyperthermia Treatment for Cancer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hyperthermia Treatment for Cancer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hyperthermia Treatment for Cancer Tier 1, Tier 2, and Tier 3
4 Hyperthermia Treatment for Cancer Market by Type
  1. 4.1 Hyperthermia Treatment for Cancer Type Introduction
  2. 4.1.1 Ultrasound Hyperthermia Device
  3. 4.1.2 Short-Wave Therapy Device
  4. 4.1.3 Infrared Therapy Device
  5. 4.1.4 Microwave Hyperthermia Device
  6. 4.2 Global Hyperthermia Treatment for Cancer Sales by Type
  7. 4.2.1 Global Hyperthermia Treatment for Cancer Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Hyperthermia Treatment for Cancer Sales by Type (2021-2032)
  9. 4.2.3 Global Hyperthermia Treatment for Cancer Sales Market Share by Type (2021-2032)
  10. 4.3 Global Hyperthermia Treatment for Cancer Revenue by Type
  11. 4.3.1 Global Hyperthermia Treatment for Cancer Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Hyperthermia Treatment for Cancer Revenue by Type (2021-2032)
  13. 4.3.3 Global Hyperthermia Treatment for Cancer Revenue Market Share by Type (2021-2032)
5 Hyperthermia Treatment for Cancer Market by Application
  1. 5.1 Hyperthermia Treatment for Cancer Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Research Institutes
  5. 5.2 Global Hyperthermia Treatment for Cancer Sales by Application
  6. 5.2.1 Global Hyperthermia Treatment for Cancer Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hyperthermia Treatment for Cancer Sales by Application (2021-2032)
  8. 5.2.3 Global Hyperthermia Treatment for Cancer Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hyperthermia Treatment for Cancer Revenue by Application
  10. 5.3.1 Global Hyperthermia Treatment for Cancer Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hyperthermia Treatment for Cancer Revenue by Application (2021-2032)
  12. 5.3.3 Global Hyperthermia Treatment for Cancer Revenue Market Share by Application (2021-2032)
6 Global Hyperthermia Treatment for Cancer Sales by Region
  1. 6.1 Global Hyperthermia Treatment for Cancer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hyperthermia Treatment for Cancer Sales by Region (2021-2032)
  3. 6.2.1 Global Hyperthermia Treatment for Cancer Sales by Region (2021-2026)
  4. 6.2.2 Global Hyperthermia Treatment for Cancer Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hyperthermia Treatment for Cancer Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hyperthermia Treatment for Cancer Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hyperthermia Treatment for Cancer Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hyperthermia Treatment for Cancer Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hyperthermia Treatment for Cancer Revenue by Region
  1. 7.1 Global Hyperthermia Treatment for Cancer Revenue by Region
  2. 7.1.1 Global Hyperthermia Treatment for Cancer Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hyperthermia Treatment for Cancer Revenue by Region (2021-2026)
  4. 7.1.3 Global Hyperthermia Treatment for Cancer Revenue by Region (2027-2032)
  5. 7.1.4 Global Hyperthermia Treatment for Cancer Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hyperthermia Treatment for Cancer Revenue (2021-2032)
  8. 7.2.2 North America Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hyperthermia Treatment for Cancer Revenue (2021-2032)
  11. 7.3.2 Europe Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hyperthermia Treatment for Cancer Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hyperthermia Treatment for Cancer Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hyperthermia Treatment for Cancer Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sjn AG Yamamoto Vinita
  2. 8.1.1 Sjn AG Yamamoto Vinita Company Information
  3. 8.1.2 Sjn AG Yamamoto Vinita Business Overview
  4. 8.1.3 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Product Portfolio
  6. 8.1.5 Sjn AG Yamamoto Vinita Recent Developments
  7. 8.2 Pyrexar Medical
  8. 8.2.1 Pyrexar Medical Company Information
  9. 8.2.2 Pyrexar Medical Business Overview
  10. 8.2.3 Pyrexar Medical Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pyrexar Medical Hyperthermia Treatment for Cancer Product Portfolio
  12. 8.2.5 Pyrexar Medical Recent Developments
  13. 8.3 Perseon Medical
  14. 8.3.1 Perseon Medical Company Information
  15. 8.3.2 Perseon Medical Business Overview
  16. 8.3.3 Perseon Medical Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Perseon Medical Hyperthermia Treatment for Cancer Product Portfolio
  18. 8.3.5 Perseon Medical Recent Developments
  19. 8.4 Omron Corporation
  20. 8.4.1 Omron Corporation Company Information
  21. 8.4.2 Omron Corporation Business Overview
  22. 8.4.3 Omron Corporation Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Omron Corporation Hyperthermia Treatment for Cancer Product Portfolio
  24. 8.4.5 Omron Corporation Recent Developments
  25. 8.5 Huahang
  26. 8.5.1 Huahang Company Information
  27. 8.5.2 Huahang Business Overview
  28. 8.5.3 Huahang Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Huahang Hyperthermia Treatment for Cancer Product Portfolio
  30. 8.5.5 Huahang Recent Developments
  31. 8.6 Celsius42 GmbH
  32. 8.6.1 Celsius42 GmbH Company Information
  33. 8.6.2 Celsius42 GmbH Business Overview
  34. 8.6.3 Celsius42 GmbH Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Celsius42 GmbH Hyperthermia Treatment for Cancer Product Portfolio
  36. 8.6.5 Celsius42 GmbH Recent Developments
  37. 8.7 Andromedic Sri
  38. 8.7.1 Andromedic Sri Company Information
  39. 8.7.2 Andromedic Sri Business Overview
  40. 8.7.3 Andromedic Sri Hyperthermia Treatment for Cancer Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Andromedic Sri Hyperthermia Treatment for Cancer Product Portfolio
  42. 8.7.5 Andromedic Sri Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hyperthermia Treatment for Cancer Value Chain Analysis
  2. 9.1.1 Hyperthermia Treatment for Cancer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hyperthermia Treatment for Cancer Production Mode & Process
  6. 9.2 Hyperthermia Treatment for Cancer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hyperthermia Treatment for Cancer Distributors
  9. 9.2.3 Hyperthermia Treatment for Cancer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst